TAITRON COMPONENTS INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data TAITRON COMPONENTS INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2015	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	5.67	6.92	7.62	8.22	6.78	6.7	8.64	8.42	6.11	4.14
Cost of revenue	3.91	7.66	4.62	4.6	3.71	3.42	4.52	4.03	2.66	2.02
Gross profit	1.76	-0.75	3	3.62	3.08	3.28	4.12	4.39	3.45	2.12
Selling, general and administrative	2.1	2.12	2.21	2.2	2.38	2.23	2.03	2.16	2.25	2.22
Selling and marketing						0	0	0
Operating income	-0.34	-2.87	0.79	1.42	0.7	1.05	2.09	2.24	1.2	-0.1
Other non-operating income	0.09	0.05	0.11	0.13	0.27	0.27	0.29	-0.45	0.84	1.23
Pre-tax income	-0.59	-3.1	0.7	1.38	0.81	1.36	2.4	1.83	2.26	1.42
Income tax	0	0.02	0.01	0.01	0	0	0.39	-1.38	0.41	0.51
Net income to minority interests	-0.01	-0.01	-0.01	-0.01	0.03	0	0	0
Net income	-0.59	-3.11	0.7	1.38	0.77	1.36	2.01	3.21	1.85	0.9
EBITDA	-0.18	-2.7	0.99	1.58	0.88	1.24	2.27	2.37	1.37	0.07
EPS, basic	-0.11	-0.56	0.13	0.25
EPS, diluted	-0.11	-0.56	0.12	0.24
Shares, basic (weighted)	5.54	5.54	5.55	5.6	5.72	5.8	5.84	6	6.01	6.02
Shares, diluted (weighted)	5.54	5.54	5.64	5.71	5.84	5.85	5.92	6.04	6.03	6.02
Dividend per share			0.10	0.11	0.13	0.15	0.17	0.29	0.20	0.20

Balance sheet

	FY2015	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
Cash and equivalents	3.69	4.02	3.25	4.49	5.31	6.65	5.97	5.22	6.21	4.21
Short-term investments						0	1.57	2.03	3.63	5.18
Receivables	0.29	0.23	0.98	0.9	1.02	0.64	0.9	0.68	0.09	0.42
Inventory	9.02	5.06	4.99	4.6	3.59	3.52	5.26	3.9	2.6	2.95
Other current assets	0.16	0.07	0.08	0.07	0.09	0.05	0.17	0.15	0.28	0.31
Total current assets	13.2	9.38	9.3	10.1	10	10.9	13.9	12	12.8	13.1
Property, plant and equipment	4.2	4.03	3.87	3.71	3.39	3.22	3.06	2.92	2.97	3.03
Total assets	18	13.9	13.6	14	13.6	14.3	17.1	17.1	18	17.6
Accounts payable	1.04	0.86	0.85	0.97	0.46	0.41	1.81	0.21	0.19	0.25
Accrued liabilities						0.45	0.92	0.79	0.97	0.82
Short-term debt		0
Total current liabilities	1.84	1.2	1.21	1.28	0.78	0.86	2.74	1	1.16	1.07
Long-term debt					0	0.16	0
Total liabilities	2.84	2.2	1.71	1.28	0.78	1.02	2.74	1	1.16	1.07
Total debt		0			0	0.16	0
Paid-in capital	10.7	10.7	10.7	10.8	11	11.1	11.2	11.4	11.5	11.5
Retained earnings	4.25	0.72	0.87	1.66	1.71	2.23	3.28	4.78	5.42	5.12
Other comprehensive income	0.16	0.16	0.14	0.13	0.04	-0.07	-0.07	-0.06	-0.06	-0.05
Shareholders' equity	15.1	11.6	11.8	12.6	12.7	13.2	14.4	16.1	16.8	16.6
Minority interests	0.1	0.1	0.1	0.1	0.1	0	0	0	0
Total equity	15.2	11.7	11.9	12.7	12.8	13.2	14.4	16.1	16.8	16.6
Total liabilities and equity	18	13.9	13.6	14	13.6	14.3	17.1	17.1	18	17.6

Cash flow statement

	FY2015	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
Net income	-0.6	-3.12	0.7	1.37	0.81	1.36	2.01	3.21	1.85	0.9
Depreciation and amortization	0.16	0.18	0.2	0.16	0.18	0.19	0.18	0.14	0.17	0.17
Stock-based compensation	0.02	0	0	0.01	0.02	0.03	0.03	0.02	0.01	0.01
Deferred income tax	0	0	0	0	0	0	0	-2.04	0.01	0.5
Change in receivables	0.15	-0.02	-0.94	0.07	-0.13	0.38	-0.26	0.22	0.59	-0.33
Change in inventory	-1.13	0.32	-0.12	1.05	2.31	1.2	-1.88	1.18	1.23	-0.36
Change in payables	0.64	-0.18	-0.01	0.12	-0.51	-0.05	1.4	-1.6	-0.02	0.06
Cash from operations	0.27	1.25	0.39	2.29	1.41	2.05	1.74	1.69	3.15	-0.26
Capital expenditures	-0.04	-0	-0.04	-0.01	-0.02	-0.02	-0.02	-0	-0.22	-0.23
Purchases of investments		0	-0.09	0	-0.19	0	-1.66	-1.23	-7.84	-3.3
Sales and maturities of investments							0.15	0.27	7.04	2.98
Cash from investing	-0.04	-0	-0.13	-0.01	-0	-0.02	-1.52	-0.97	-1.01	-0.55
Stock issued		0	0.04	0.06	0.13	0.09	0.08	0.21	0.05	0
Share buybacks	-0.02	0
Dividends paid	0	-0.41	-0.55	-0.59	-0.72	-0.84	-0.97	-1.7	-1.2	-1.2
Cash from financing	-0.02	-0.91	-1.01	-1.03	-0.59	-0.59	-0.89	-1.5	-1.15	-1.2
Exchange rate effect	0	-0	-0.01	-0.02	0	-0.1
Net change in cash	0.22	0.33	-0.77	1.24	0.82	1.34	-0.68	-0.76	0.99	-2
Free cash flow	0.24	1.24	0.35	2.29	1.4	2.04	1.72	1.69	2.94	-0.49
Interest paid	0.05	0.04	0.04	0.01	0	0	0	0	0
Income taxes paid	0.01	0	0	0	0	0	0	0.71	0.56	0.2

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2025; growth uses fiscal years. Valuation uses the share price of $2.12 on September 28, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	58.6%	Gross profit / revenue.
Operating margin	-50.6%	Operating income / revenue.
EBITDA margin	-44.9%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-13.4%	Pre-tax income / revenue.
Net margin	-27.4%	Net income / revenue.
FCF margin	19.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	20.1%	Cash from operations / revenue.
Return on equity (ROE)	-6.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-5.7%	Net income / average total assets.
Return on invested capital (ROIC)	-12.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	61.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.5%	Capital expenditures / revenue.
D&A / revenue	5.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-32.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-21.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-9.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-38.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-19.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-7.2%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-108.7%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-95.0%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-68.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-39.8%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-51.1%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-23.4%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	3.1%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-108.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	-116.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	6.6%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	9.9%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-1.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	4.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	5.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-2.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	1.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	5.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.6%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	6.26x	Current assets / current liabilities.
Quick ratio	5.11x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	4.89x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	11.8%	Total liabilities / total assets.
Working capital	$10.6M	Current assets - current liabilities.
Tangible book value	$15.1M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.21x	Revenue / average total assets.
Fixed asset turnover	1.23x	Revenue / average property, plant and equipment.
Inventory turnover	0.70x	Cost of revenue / average inventory.
Days inventory	522 days	365 x average inventory / cost of revenue.
Receivables turnover	7.97x	Revenue / average receivables.
Days sales outstanding	46 days	365 x average receivables / revenue.
Days payables	122 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	445 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	2.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.16	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$0.59	Revenue / diluted weighted shares.
FCF per share	$0.12	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.12	Cash from operations / diluted weighted shares.
Book value per share	$2.50	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$2.50	Tangible book value / shares outstanding.
Cash per share	$1.64	(Cash + short-term investments) / shares outstanding.
Dividends / FCF	160.1%	Dividends paid / free cash flow, when free cash flow is positive.

What was TAITRON COMPONENTS INC's revenue in fiscal 2024?

TAITRON COMPONENTS INC reported revenue of $4.1M for fiscal 2024, 32.2% lower than the year before.

Was TAITRON COMPONENTS INC profitable in fiscal 2024?

Yes. Net income was $902.0K, a net margin of 21.8%.

How much free cash flow did TAITRON COMPONENTS INC generate in fiscal 2024?

Cash from operations of $258.0K minus capital expenditures of $232.0K left free cash flow of -$490.0K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to TAITRON COMPONENTS INC